Arizona Tribune - Boulevard

NYSE - LSE

CMSC	-0.53%	20.81	$
CMSD	-0.34%	20.69	$
JRI	-0.58%	12.14	$
BCE	-0.59%	23.67	$
RIO	0.42%	103.27	$
BCC	2.64%	79.21	$
RBGPF	0%	70	$
RYCEF	0.7%	19.92	$
RELX	-3.21%	35.51	$
NGG	-0.06%	78.12	$
VOD	1.89%	16.9	$
BTI	-1.12%	55.35	$
BP	0.52%	43.81	$
AZN	-1.27%	162.7	$
GSK	-1.96%	49.89	$

Featured

Nepal tunnel rescue revives hopes 10 days after flood

Rescuers in Nepal pulled a Chinese national alive on Saturday from a tunnel buried by debris, as emergency response teams dug with new vigour in the search for missing people 10 days after catastrophic flooding.

How haze from Indonesian fires impacts Southeast Asia

Thick smog has blanketed parts of Indonesia as the vast archipelago for weeks battles to contain fires that have burned large swathes of Borneo and Sumatra.

Last news

Interactive Strength Inc. (Nasdaq: TRNR) Plans to Announce More Acquisition News at Conference Presentation on February 11

AUSTIN, TX / ACCESS Newswire / February 6, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced its 2025 exhibition season will kick off with a fireside chat with Sweatworks' Mohammed Iqbal at LA's Connected Health & Fitness Summit from February 11-13, 2025, where the Company expects to discuss its 2025 plans and deliver an update on its next possible acquisition, previously announced in December 2024.

World Tumor Registry Names Dr. Edi Brogi as Inaugural Chair of its Breast Cancer Registry

PITTSBURGH, PA / ACCESS Newswire / February 6, 2025 / Established in 2021, the World Tumor Registry is being developed as a collection of registries or individual cancer sites, each to contain thousands of searchable digital microscopic images of cancer accompanied by clinical, genetic, and treatment information contributed from every region of the world and annotated by the WTR experts. The first of such registries, dedicated to thyroid cancer, went live in March of 2024. A Breast Cancer Registry is the second project, with a planned public launch at the end of 2025.

Bausch Health Provides Update on Strategic Alternatives

LAVAL, QC / ACCESS Newswire / February 6, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health"), a global, diversified pharmaceutical company enriching lives through a relentless drive to deliver better health outcomes, issued the following update on a potential sale of its subsidiary, Bausch + Lomb Corporation (NYSE:BLCO)(TSX:BLCO), which was disclosed in December 2024 following a regulatory request:

KALEO Frontman JJ Julius Son and Entrepreneur Robert Wessman to Launch Unique Limited-Edition Wine Collection at WineParis

An Icelandic Merger of Music and Winemaking

Zomedica Launches the TRUFORMA(R) Enhanced Endogenous ACTH Assay to aid in Equine PPID Diagnosis

Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform

Already Bold, Specificity Gets Bolder with New Hire, Chris Gruening as Vice President of Client Services

TAMPA, FL / ACCESS Newswire / February 6, 2025 / Specificity (OTC PINK:SPTY), a leading digital marketing firm specializing in precision targeting, is pleased to announce the appointment of Chris Gruening as its new Vice President of Client Services. Gruening brings a wealth of experience in building strong client relationships and spearheading strategies that drive success. His leadership will play a critical role in supporting Specificity's ongoing mission to deliver tailored, high-performance marketing solutions for its growing portfolio of brands, including Specificity, Put-Thru, and Intent Buyers.

US Marine vet acquitted in NY subway death joins tech firm

A US Marine veteran who was acquitted in the chokehold death of a homeless man on the New York subway -- a high-profile case highlighting the divisive issue of race in America -- has been hired by a major Silicon Valley firm allied with Donald Trump.

Sweden mourns after school massacre

Sweden on Wednesday mourned the victims of its worst mass killing as police indicated that the gunman likely shot himself after killing 10 people at an adult education centre.

Chelsea star Kerr says treated differently because of 'skin colour'

Chelsea striker Sam Kerr Wednesday told a court she was treated differently by police "because of the colour of my skin" after "fearing for my life" following an incident with a taxi driver.

Swedish king leads mourning after school massacre

Sweden on Wednesday mourned the victims of its worst mass killing as police indicated that the gunman likely shot himself after killing 10 people at an adult education centre.

Chelsea star Kerr 'feared for my life' during taxi ride

Chelsea striker Sam Kerr said she "feared for my life" while she and her partner were in the back of a taxi moments before one of them smashed the vehicle's rear window.

Swedish police say school killing spree gunman likely shot himself

Swedish police indicated Wednesday that a gunman who slaughtered 10 people at an adult education centre shot himself as the country mourned its worst mass killing.

Sweden reels from worst mass shooting in its history

Sweden on Wednesday was recovering from the deadliest mass shooting in its history after 10 people -- as well as the suspected gunman -- were killed at an education centre in the city of Orebro, with many questions still unanswered.

Blackbox Press Event and Regional Government Roundtable

It being our first event, we began by explaining Blackbox's mission statement and the social context that led to our launch. General Manager Taiki Iwasaki talked about the growing support for startups - especially foreign startups - in Japan over the last few years.

Aytu BioPharma to Report Fiscal 2025 Second Quarter Operational and Financial Results on February 12, 2025

DENVER, CO / ACCESS Newswire / February 5, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its second quarter of fiscal 2025, after the market close on Wednesday, February 12, 2025. The Company has scheduled a conference call and webcast that same day, Wednesday, February 12, 2025, at 4:30 p.m. Eastern time, to review the results followed by a question and answer session.

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss decline of $1.1 million

Registration Now Open for World of Coffee 2025 in Geneva: The Premier Event for Coffee Professionals

Join Over 13,000 Attendees and 430+ Exhibitors at Europe's Largest Specialty Coffee Trade Show

Clover Sonoma(R) Unveils Pasture Raised Organic A2 4% Whole Milk

"We're thrilled to introduce A2 milk as a potential solution for those who struggle to digest dairy products," said Clover Sonoma Chief Executive Officer John Coletta. "It matters where your dairy comes from, which is why we proudly partner with local Northern California family farms raising Jersey and Guernsey cows that naturally produce the A2 protein."

As Valentine’s Day Approaches, Bestselling Memoir Encourages Self-Love as Key to Thriving Relationships, Life

DENVER, CO / ACCESS Newswire / February 5, 2025 / What happens when 'I do' becomes 'I don't'? Love is in the air with Valentine's Day around the corner, but this bestselling author encourages women to reflect inward and seek self-love first.

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

CHICAGO, IL / ACCESS Newswire / February 5, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company")(NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of a patent application for multiple sclerosis (MS), a disabling autoimmune disorder affecting millions worldwide.

Church of Ambrosia Joins Forces with the Oakland Hyphae for the 5th Annual Spirituality and Beyond - April 19th and 20th, 2025

OAKLAND, CA / ACCESS Newswire / February 5, 2025 / A groundbreaking spiritual and psychedelic gathering is coming to the San Francisco Bay Area on Bicycle Day (4/19) and 4/20. This year, Easter Sunday coincides with 4/20, adding an extra layer of significance to this once-in-a-lifetime experience. The Church of Ambrosia, the world's largest psychedelic church with over 120,000 members, is merging its annual Easter celebration, Spirituality and Beyond, with the Oakland Psychedelic Conference for an unprecedented two-day event.

CORRECTING AND REPLACING: HydraPatch(R) & Zoot Sports Announce Partnership

NORTH BRUNSWICK, NJ / ACCESS Newswire / February 5, 2025 / HydraPatch® and Zoot Sports have entered a partnership, to assist triathletes of all skill levels with managing their hydration levels and recovery efforts.

Lexaria Updates its Ongoing Human Study GLP-1-H24-4

Registered Phase-1b 12-week study investigating safety, diabetes control, and weight loss

The Icon in Culinary Arts - Chef Alan Coxon, Challanges the Stigma Surrounding the Taste of Collagen Peptides

Chef Alan Coxon, an Icon in the Culinary Arts, Sets a New Standard by Partnering With Enchant Brands, an Innovator in Nutrition Powders, to Challenge and Redefine the Stigma Surrounding the Taste of Collagen Peptides.

CV Sciences Unveils New Aura Collection THC Fizz Tablets

The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home.

Deep Blue Sports + Entertainment Announces Joint Venture With Always Alpha, Creating Women's Sports' First Full-Service Management Offering

Always Alpha co-founders Allyson Felix and CEO Cosette Chaput join forces with Deep Blue's founder and CEO Laura Correnti to elevate the women's sports industry by creating the largest firm and first one-stop shop dedicated exclusively to women's sports

Jerash Holdings (US), Inc. Declares Quarterly Dividend

FAIRFIELD, NJ / ACCESS Newswire / February 5, 2025 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company's common stock. The dividend is payable on or about February 25, 2025 to the stockholders of record as of February 18, 2025.

Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comments on Current Landscape for Pain Treatment

~ Positive Enrollment Progress and Safety Data ~~ FDA Attention Establishes Momentum in the Pain Treatment Space ~

Polaris Renewable Energy Declares Quarterly Dividend

TORONTO, ON / ACCESS Newswire / February 5, 2025 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding.

CTT Pharma Adds Independent Director With NIH/NSF Experience

TAMPA, FL / ACCESS Newswire / February 5, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC PINK:CTTH) is pleased to announce adding Dr. Katherine Cole as an Independent Director for CTT. Dr. Cole. a Ph.D. in Pathology from the University of Maryland School of Medicine. Following her Ph.D. she spent 3 years at the National Cancer Institute(NCI) at the National Institutes of Health(NIH) where she spent her time focused on anti-cancer mechanisms of novel chemotherapeutic compounds. From there Dr. Cole worked at four different universities as a Biomedical scientist, professor, and eventually as a vice Provost and Dean. She has published twenty-two peer reviewed papers and has been granted two patents related to a human liver cell line. Dr. Cole has been awarded many notable grants including grants from the National Science Foundation(NSF) and the Howard Hughes Medical Institute. Dr. Cole's professional development as a scientist, an educator and a university-level administrator has provided her with a distinct scientific perspective and an ability to critically analyze meaningful data and research design. Her Ph.D. in Pathology from the University of Maryland School of Medicine and postdoctoral experience at the NIH/NCI in cancer research have positioned her well to not only understand the science behind this technology, but the impact from a human pathological perspective. CTT is honored to have Dr. Cole on our team and looks forward to her contributions.

Forte Group Appoints Dallas Pretty as Chief Financial Officer

VANCOUVER, BC / ACCESS Newswire / February 5, 2025 / Forte Group Holdings Inc. (CSE:FGH)(OTC PINK:FGHFF)(FSE:7BC0, WKN:A40L1Z)("Forte Group" or the "Company"), a diversified lifestyle and wellness consumer packaged goods company, announces the appointment of Dallas Pretty, CPA, CA, as its Chief Financial Officer and Corporate Secretary, effective February 4, 2025. Mr. Pretty succeeds John Campbell, who has resigned from his roles as Chief Financial Officer, Chief Strategy Officer, and Corporate Secretary effective February 4, 2025.

Reservoir Media Announces Third Quarter Fiscal 2025 Results

Strong Results in Both Segments Grew Total Revenue by 19% Including AcquisitionsKey Catalog Additions and Disciplined Cost Controls Drive Margin GrowthRaises Fiscal 2025 Financial Outlook

Arizona Tribune - Boulevard (English)